Evidence & regulatory context
- Mechanism
- Methanolic wormwood (Artemisia absinthium) aerial-part extract in ointment; multi-component botanical.
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MixedWoundWistar albino rats (wound healing and acute dermal irritation); Swiss albino mice (acute oral toxicity)Female for the acute oral toxicity mice (nulliparous, non-pregnant); sex of the rats not statedn = Wound healing: 7 groups of 5 rats (35 rats). Acute dermal i…Topical (cutaneous) for wound healing and dermal irritation; oral gavage for acute oral toxicity500 mg of ointment per rat per topical application (5% or 1…Topical treatment started on the day of wounding, immediately after excision an…
Model: Full-thickness excisional skin wound: a 2.5 cm diameter circular wound excised from the shaved lumbar dorsal region under ketamine (90 mg/kg) and xylazine (10 mg/kg) intraperitoneal anaesthesia
MEO 5% and MEO 10% significantly improved wound contraction versus untreated animals (p < 0.001), with MEO 10% reaching 81.49 +/- 2.83% contraction compared with 84.52 +/- 0.80% for the reference drug Cicatryl-Bio and no significant difference between them. Histology showed greater collagen deposit…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.